Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 4/20 | 0.53 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.53 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | BLM | P54132 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.46 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.44 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11196604 | 0.97 | TYMS (0.55) | TYMSLMNASLC22A6FOLH1NFKB1 | |
| SCHEMBL454023 | 0.92 | LMNA (0.58) | TYMSLMNASLC22A6FOLH1NFKB1 | |
| Butane SCHEMBL7718806 | 0.91 | LPAR3 (0.54) | SLC22A6TSHRMEN1KMT2ATDP1 | |
| Alcohol SCHEMBL1487742 | 0.91 | LPAR3 (0.48) | TYMSSLC22A6TSHRMEN1KMT2A | |
| SCHEMBL4536540 | 0.90 | TSHR (0.60) | TYMSLMNASLC22A6NFKB1PMP22 | |
| SCHEMBL4531743 | 0.90 | TSHR (0.60) | TYMSLMNASLC22A6NFKB1PMP22 | |
| SCHEMBL2939530 | 0.90 | TSHR (0.60) | TYMSLMNASLC22A6NFKB1PMP22 | |
| SCHEMBL20835969 | 0.90 | TSHR (0.60) | TYMSLMNASLC22A6NFKB1PMP22 | |
| SCHEMBL4533111 | 0.90 | TSHR (0.60) | TYMSLMNASLC22A6NFKB1PMP22 | |
| SCHEMBL4535332 | 0.90 | TSHR (0.60) | TYMSLMNASLC22A6NFKB1PMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 397 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4536217-A1 | CO-AGENTS AS THERAPY AGAINST ANAEROBIC PATHOGENS | Fleurir Abx LLC (US) | 2025-04-16 | — | — | EP | claimed |
| US-20250075020-A1 | WATER-RETAINING MATERIAL, WATER-RETAINING PROTON EXCHANGE MEMBRANE, PREPARATION METHOD AND APPLICATION THEREOF | SOUTHERN UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2025-03-06 | — | — | US | claimed |
| WO-2024237137-A1 | QUANTUM DOT COMPOSITION, RESIN COMPOSITION, AND WAVELENGTH CONVERSION MATERIAL | 信越化学工業株式会社 | 2024-11-21 | — | — | WO | claimed |
| WO-2024138649-A1 | WATER RETENTION MATERIAL, WATER RETENTION PROTON EXCHANGE MEMBRANE, PREPARATION METHOD THEREFOR AND USE THEREOF | 南方科技大学 | 2024-07-04 | — | — | WO | claimed |
| WO-2024116801-A1 | QUANTUM DOT COMPOSITION, RESIN COMPOSITION USING SAME AND WAVELENGTH CONVERSION MATERIAL | 信越化学工業株式会社 | 2024-06-06 | — | — | WO | claimed |
| EP-3731958-B1 | SURFACTANT COMPOSITIONS AND USES AS INVERTERS | ECOLAB USA INC (US) | 2024-02-07 | — | — | EP | claimed |
| WO-2023239822-A1 | CO-AGENTS AS THERAPY AGAINST ANAEROBIC PATHOGENS | FLEURIR ABX LLC (US) | 2023-12-14 | — | — | WO | claimed |
| US-20230398101-A1 | Co-agents as Therapy Against Anaerobic Pathogens | FLEURIR ABX LLC (US) | 2023-12-14 | — | — | US | claimed |
| US-11807830-B2 | Surfactant compositions and use thereof | ECOLAB USA INC. (US) | 2023-11-07 | — | — | US | claimed |
| US-20230116790-A1 | SURFACTANT COMPOSITIONS AND USE THEREOF | ECOLAB USA INC. | 2023-04-13 | — | — | US | claimed |
| EP-0453871-B1 | Salts of triazine derivatives with oxygenated acids of phosphorus | MINI RICERCA SCIENT TECNOLOG (IT) | 1996-02-07 | — | — | EP | claimed |
| US-5359064-A | Used in preperation of self-extinguishing polymeric composition as flame-retardent additives | Ministero Dell `Universita` e Della Ricerca Scientifica e Tecnologica (IT) | 1994-10-25 | — | — | US | claimed |
| US-5344931-A | Salts of triazinic compounds with phosphorus oxyacids, and use of said compounds in self-extinguishing polymeric compositions | MINISTERO DELL'UNIVERSITA' E DELLA RICERCA SCIENTIFICA E TECHNOLOGICA (IT) | 1994-09-06 | — | — | US | claimed |
| US-5225463-A | Thermoplastic polymers or elastomers with triamino-s-triazine compounds and salified with oxygenated phosphorous | MINISTERO DELL'UNIVERSITA E DELLA RICERCA SCIENTIFICA E TECNOLOGICA (IT) | 1993-07-06 | — | — | US | claimed |
| EP-0537837-A1 | Salts of triazinic compounds with phosphorus oxyacids, and use of said compounds in self-extinguishing polymeric compositions | MINISTERO DELL' UNIVERSITA' E DELLA RICERCA SCIENTIFICA E TECNOLOGICA (IT) | 1993-04-21 | — | — | EP | claimed |
| US-5182388-A | Anti-flame additives for thermoplastics | MINISTERO DELL' UNIVERSITA' E DELLA RICERCA SCIENTIFICA E TECNOLOGICA (IT) | 1993-01-26 | — | — | US | claimed |
| EP-0466137-A2 | Salts of triazine derivatives with oxygenated acids of phosphorus and their use in self-extinguishing polymeric compositions | MINISTERO DELL' UNIVERSITA' E DELLA RICERCA SCIENTIFICA E TECNOLOGICA (IT) | 1992-01-15 | — | — | EP | claimed |
| EP-0453871-A1 | Salts of triazine derivatives with oxygenated acids of phosphorus | MINISTERO DELL' UNIVERSITA' E DELLA RICERCA SCIENTIFICA E TECNOLOGICA (IT) | 1991-10-30 | — | — | EP | claimed |
| EP-0451807-A2 | Self-extinguishing polymeric compositions | MINISTERO DELL' UNIVERSITA' E DELLA RICERCA SCIENTIFICA E TECNOLOGICA (IT) | 1991-10-16 | — | — | EP | claimed |
| US-4390690-A | TETRAVALENT METAL | OCCIDENTAL RESEARCH CORP. (US) | 1983-06-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11807830-B2 | Surfactant compositions and use thereof | DEGS1, DSG1, SGMS2 | TYMS 3734/4885LMNA 1707/4885SLC22A6 2452/4885 |
| US-20230116790-A1 | SURFACTANT COMPOSITIONS AND USE THEREOF | DEGS1, DSG1, SGMS2 | TYMS 3734/4885LMNA 1707/4885SLC22A6 2452/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.